Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akio Mori

Showing results (221-230 of 236) with videos related to

Pageof 24
Sort By:
British Journal of Haematology|April 17, 2023
Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosisShota Yokoyama, Masahiro Onozawa, Shota Yoshida, et al.
International Journal of Hematology|December 26, 2022
Clinical features of complex karyotype in newly diagnosed acute myeloid leukemiaShota Yoshida, Masahiro Onozawa, Naoki Miyashita, et al.
Hematology (Amsterdam, Netherlands)|February 10, 2026
Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changesToshihiro Matsukawa, Shota Yoshida, Masahiro Onozawa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2009
Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study GroupMasahiro Onozawa, Satoshi Hashino, Yoshifumi Haseyama, et al.
Human Molecular Genetics|October 11, 2019
Mutations in CHCHD2 cause α-synuclein aggregationAya Ikeda, Kenya Nishioka, Hongrui Meng, et al.
European Journal of Haematology|July 19, 2023
Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AMLToru Miyajima, Masahiro Onozawa, Shota Yoshida, et al.
European Journal of Haematology|April 17, 2018
Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic-phase chronic myeloid leukemiaShuichi Ota, Toshihiro Matsukawa, Satoshi Yamamoto, et al.
International Journal of Hematology|April 8, 2022
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapyChikashi Yoshida, Takeshi Kondo, Tomoki Ito, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 12, 2016
A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/LymphomaSatoshi Iyama, Tsutomu Sato, Hirofumi Ohnishi, et al.
International Journal of Hematology|April 22, 2026
Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort studyShota Yokoyama, Masahiro Onozawa, Hiroyuki Kimura, et al.
Pageof 24

Showing results (221-230 of 236) with videos related to

Sort By:
Pageof 24
British Journal of Haematology|April 17, 2023
Subclinical minute FLT3-ITD clone can be detected in clinically FLT3-ITD-negative acute myeloid leukaemia at diagnosisShota Yokoyama, Masahiro Onozawa, Shota Yoshida, et al.
International Journal of Hematology|December 26, 2022
Clinical features of complex karyotype in newly diagnosed acute myeloid leukemiaShota Yoshida, Masahiro Onozawa, Naoki Miyashita, et al.
Hematology (Amsterdam, Netherlands)|February 10, 2026
Adverse karyotype amplifies risk in secondary acute myeloid leukemia (AML) and AML with myelodysplasia-related changesToshihiro Matsukawa, Shota Yoshida, Masahiro Onozawa, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 20, 2009
Incidence and risk of postherpetic neuralgia after varicella zoster virus infection in hematopoietic cell transplantation recipients: Hokkaido Hematology Study GroupMasahiro Onozawa, Satoshi Hashino, Yoshifumi Haseyama, et al.
Human Molecular Genetics|October 11, 2019
Mutations in CHCHD2 cause α-synuclein aggregationAya Ikeda, Kenya Nishioka, Hongrui Meng, et al.
European Journal of Haematology|July 19, 2023
Clinical implications of NUP98::NSD1 fusion at diagnosis in adult FLT3-ITD positive AMLToru Miyajima, Masahiro Onozawa, Shota Yoshida, et al.
European Journal of Haematology|April 17, 2018
Severe adverse events by tyrosine kinase inhibitors decrease survival rates in patients with newly diagnosed chronic-phase chronic myeloid leukemiaShuichi Ota, Toshihiro Matsukawa, Satoshi Yamamoto, et al.
International Journal of Hematology|April 8, 2022
Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapyChikashi Yoshida, Takeshi Kondo, Tomoki Ito, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 12, 2016
A Multicenter Retrospective Study of Mogamulizumab Efficacy in Adult T-Cell Leukemia/LymphomaSatoshi Iyama, Tsutomu Sato, Hirofumi Ohnishi, et al.
International Journal of Hematology|April 22, 2026
Philadelphia chromosome-negative but BCR::ABL1-positive acute lymphoblastic leukemia: a real-world multicenter cohort studyShota Yokoyama, Masahiro Onozawa, Hiroyuki Kimura, et al.
Pageof 24